Your session is about to expire
← Back to Search
The seven visit telemedicine protocol for Chronic Heart Failure
N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (day following discharge), 30 and 90 days (following discharge)
Awards & highlights
Study Summary
This trial aims to study whether an intensive, 7-visit series of medical and social services helps newly discharged, low-income Medicare patients with COPD or CHF.
Eligible Conditions
- Chronic Heart Failure
- Chronic Obstructive Pulmonary Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (day following discharge), 30 and 90 days (following discharge)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (day following discharge), 30 and 90 days (following discharge)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Hospital revisits (Emergency Department or Inpatient)
Self-reported declarations on hospital revisits (Emergency Department or Inpatient)
Secondary outcome measures
Self efficacy for managing medication and treatment
Other outcome measures
National Quality Forum's 3-item Care Transition Measure
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Seven telemedicine visitsExperimental Treatment1 Intervention
Will receive the seven visit telemedicine protocol
Group II: Control - Usual CareActive Control1 Intervention
Will not receive the protocol
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,584 Previous Clinical Trials
2,280,043 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have chronic obstructive pulmonary disease (COPD).You must be able to speak English.You have difficulty thinking or remembering things clearly.You must be younger than 60 years old.You have long-term heart problems.
Research Study Groups:
This trial has the following groups:- Group 1: Seven telemedicine visits
- Group 2: Control - Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research study still recruiting participants?
"Data hosted on clinicaltrials.gov verifies that this trial is currently recruiting patients to participate. The investigation was first advertised on the 31st of January 2022 and its details were most recently amended at the close of October in the same year."
Answered by AI
How many individuals are partaking in this experiment?
"Indeed, the trial is still active and ongoing. Per clinicaltrials.gov, this trial was posted on January 31st 2022 and most recently updated on October 31st 2022. 70 participants are needed from just 1 site to complete the study."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger